Sales 2025 by Business Segment

Sales 2025 by Geography

Historical Breakdown of Revenue by Business Segments

: Breakdown by Business Segment

Breakdown by Business Segment (USD)
Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025

All Other

- - - -147M -

EBITDA

- - - -117M -

Intersegment Eliminations

-71.48M -118M -151M - -

Drug Stores and Pharmacies

        

Retail

592M 721M 741M 672M -

Total Assets

1.3B 1.26B 1.14B - -

Income Tax Expense

50.4M 53.32M 100M - -

CAPEX

-56.96M - - - -

EBITDA

- - - 183M -

D&A

41.78M 63.27M 67.28M - -

Net Income

-72.86M -164M -116M - -

Medicinal Chemicals and Botanical Products

        

Wholesale

218M 276M 348M 353M -

Total Assets

1.24B 1.14B 1.18B - -

Income Tax Expense

53.72M 52.15M 44.69M - -

CAPEX

-91.55M - - - -

EBITDA

- - - 198M -

D&A

54.46M 78.12M 73.85M - -

Net Income

58.18M -105M -1.11M - -

Cultivation, Manufacturing, and Distribution, and Sale of Cannabis

- - - - -

Interest Expense

- - - - -

Income Tax Expense

- - - - -

Total Assets

- - - - -

CAPEX

- - - - -

EBT

- - - - -

Gross Profit

- - - - -

D&A

- - - - -

Operating Income

- - - - -

Net Income

- - - - -

Geographical Revenue Distribution History

Geographical breakdown of sales (USD)
Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025

United States

738M 879M 938M 879M -

Total Assets

2.55B 2.4B 2.32B 1.99B -

Interest Expense

-24.27M -49.43M -59.79M -54.76M -

Income Tax Expense

104M 105M 145M 41.94M -

D&A

96.24M 150M 152M 151M -

CAPEX

-150M -119M -36.33M -99.05M -

Gross Profit

335M 423M 475M 444M -

Net Income

-14.68M -269M -117M -342M -

EBT

91.96M -163M 27.8M -300M -

Operating Income

108M -161M 84.78M -237M -
SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW